MedPath

Role of Navayasa Lauh and Raktmitrarka in the management of Pandu Roga (Iron deficiency anemia).

Phase 2
Conditions
Health Condition 1: D509- Iron deficiency anemia, unspecified
Registration Number
CTRI/2022/05/042636
Lead Sponsor
ational Institute of Ayurveda Deemed to be University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Patient willing to participate in clinical trial and sign consent form.

2. Age: between 18 to 59 years .

3. Sex: Male and Female patients .

4. Patients with Hb % within the range of 6-10 gm/dl.

5. Patients having any clinical signs and symptoms of

Pandu Roga (iron deficiency anemia).

Exclusion Criteria

1. Patient not willing to participate in clinical trial

2. Age: below 18 years and above 59 years.

3. Hb % less than 6 gm/dl.

4. Anemia caused by other than iron deficiency.

5. Patient participated in any clinical trial with in last six

months.

6. Patients suffering from chronic disorder like

hypothyroidism, hyperthyroidism, diabetes mellitus, hypertension, rheumatoid arthritis etc.

7. Patient suffering from serious diseases like CKD, IHD, CCF, malignancy etc.

8. Patient suffering from any continuing blood loss eg.

Hematemesis, melena, bleeding piles .

9. Pregnant or lactating women.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Changes in objective parameter CBC,PBS,Sr Iron, Sr Ferritin,TIBCTimepoint: 30 days
Secondary Outcome Measures
NameTimeMethod
Changes in the clinical sign and symptoms of Pandu Roga (Iron deficiency anemia) Pallor, Generalised weakness, Headache, Palpitation, Anorexia, Dyspnoea, Leg cramps, Dryness, Heaviness in body, Fatigue <br/ ><br>Timepoint: 30 days
© Copyright 2025. All Rights Reserved by MedPath